The Prospects for “Personalized Medicine” in Drug Development and Drug Therapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-02

AUTHORS

J Woodcock

ABSTRACT

There has been much recent discussion about the advent of "personalized medicine," but controversy exists over its exact definition; how, when, and whether it will be brought about, and what means could be used to measure its attainment. In fact, the concept of "personalized medicine" is a sort of shorthand used to represent the logical next steps in progression of medical science toward greater mechanistic understanding of health, disease, and treatment. This shorthand is attractive to the public because of its intuitive appeal, and irritating to the biomedical community because it glosses over the very real scientific and implementation challenges. This paper evaluates the trajectory and promise of these next steps for the currently problematic states of both drug development and therapy. More... »

PAGES

164-169

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.clpt.6100063

DOI

http://dx.doi.org/10.1038/sj.clpt.6100063

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001636899

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17259943


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2202", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "History and Philosophy of Specific Fields", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/22", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Philosophy and Religious Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Approval", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Industry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Forecasting", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient-Centered Care", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "United States Food and Drug Administration", 
          "id": "https://www.grid.ac/institutes/grid.417587.8", 
          "name": [
            "Deputy Commissioner for Operations, Food and Drug Administration Rockville Maryland USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Woodcock", 
        "givenName": "J", 
        "id": "sg:person.01107576476.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107576476.16"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2007-02", 
    "datePublishedReg": "2007-02-01", 
    "description": "There has been much recent discussion about the advent of \"personalized medicine,\" but controversy exists over its exact definition; how, when, and whether it will be brought about, and what means could be used to measure its attainment. In fact, the concept of \"personalized medicine\" is a sort of shorthand used to represent the logical next steps in progression of medical science toward greater mechanistic understanding of health, disease, and treatment. This shorthand is attractive to the public because of its intuitive appeal, and irritating to the biomedical community because it glosses over the very real scientific and implementation challenges. This paper evaluates the trajectory and promise of these next steps for the currently problematic states of both drug development and therapy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.clpt.6100063", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "81"
      }
    ], 
    "name": "The Prospects for \u201cPersonalized Medicine\u201d in Drug Development and Drug Therapy", 
    "pagination": "164-169", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "07cc025cf6e2cbdf136af1f95369f5d49864f8f6b41609a988b55eb4a826ea96"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17259943"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0372741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.clpt.6100063"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001636899"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.clpt.6100063", 
      "https://app.dimensions.ai/details/publication/pub.1001636899"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://onlinelibrary.wiley.com/doi/10.1038/sj.clpt.6100063/abstract"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100063'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100063'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100063'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100063'


 

This table displays all metadata directly associated to this object as RDF triples.

97 TRIPLES      20 PREDICATES      36 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.clpt.6100063 schema:about N566279b325ed41ffa19ea25075a764e6
2 N795462a0bf3241bb9749a09f271ff058
3 N8f8c13af06ac4a86a48277e0b01afbe0
4 N9232bedcb64a4cdfb546134a4e4f0266
5 N9971f24efe8e49e591000818bba366a1
6 Naa46b7f4ff5b42a9afd566dc32b2ac22
7 Ncef136755a1b4756bc4d4325ba002d88
8 anzsrc-for:22
9 anzsrc-for:2202
10 schema:author N706ff27717894affb1f943662f28318f
11 schema:datePublished 2007-02
12 schema:datePublishedReg 2007-02-01
13 schema:description There has been much recent discussion about the advent of "personalized medicine," but controversy exists over its exact definition; how, when, and whether it will be brought about, and what means could be used to measure its attainment. In fact, the concept of "personalized medicine" is a sort of shorthand used to represent the logical next steps in progression of medical science toward greater mechanistic understanding of health, disease, and treatment. This shorthand is attractive to the public because of its intuitive appeal, and irritating to the biomedical community because it glosses over the very real scientific and implementation challenges. This paper evaluates the trajectory and promise of these next steps for the currently problematic states of both drug development and therapy.
14 schema:genre research_article
15 schema:inLanguage en
16 schema:isAccessibleForFree false
17 schema:isPartOf N5d8e602f1781457a9aa4afe9e63fdf7a
18 Na4e8c56b28944be4b73081da3703500e
19 sg:journal.1017409
20 schema:name The Prospects for “Personalized Medicine” in Drug Development and Drug Therapy
21 schema:pagination 164-169
22 schema:productId N42268c9ef8a54b67b0d01dab11055e52
23 N6461fc3edf3945daae703ebc3cfe471b
24 Ncbce0da4c45f4b1480f95b7c8dfa015d
25 Nf012d4789d0a4a419f9a7f4bd6403136
26 Nf7fb622de8de4be99f8d14a0603820f1
27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001636899
28 https://doi.org/10.1038/sj.clpt.6100063
29 schema:sdDatePublished 2019-04-10T16:56
30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
31 schema:sdPublisher N0187edb3648a4a0f82f2b1a979a73326
32 schema:url http://onlinelibrary.wiley.com/doi/10.1038/sj.clpt.6100063/abstract
33 sgo:license sg:explorer/license/
34 sgo:sdDataset articles
35 rdf:type schema:ScholarlyArticle
36 N0187edb3648a4a0f82f2b1a979a73326 schema:name Springer Nature - SN SciGraph project
37 rdf:type schema:Organization
38 N42268c9ef8a54b67b0d01dab11055e52 schema:name readcube_id
39 schema:value 07cc025cf6e2cbdf136af1f95369f5d49864f8f6b41609a988b55eb4a826ea96
40 rdf:type schema:PropertyValue
41 N566279b325ed41ffa19ea25075a764e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
42 schema:name Drug Approval
43 rdf:type schema:DefinedTerm
44 N5d8e602f1781457a9aa4afe9e63fdf7a schema:volumeNumber 81
45 rdf:type schema:PublicationVolume
46 N6461fc3edf3945daae703ebc3cfe471b schema:name nlm_unique_id
47 schema:value 0372741
48 rdf:type schema:PropertyValue
49 N706ff27717894affb1f943662f28318f rdf:first sg:person.01107576476.16
50 rdf:rest rdf:nil
51 N795462a0bf3241bb9749a09f271ff058 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Drug Industry
53 rdf:type schema:DefinedTerm
54 N8f8c13af06ac4a86a48277e0b01afbe0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
55 schema:name Drug Therapy
56 rdf:type schema:DefinedTerm
57 N9232bedcb64a4cdfb546134a4e4f0266 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name Drug Design
59 rdf:type schema:DefinedTerm
60 N9971f24efe8e49e591000818bba366a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Patient-Centered Care
62 rdf:type schema:DefinedTerm
63 Na4e8c56b28944be4b73081da3703500e schema:issueNumber 2
64 rdf:type schema:PublicationIssue
65 Naa46b7f4ff5b42a9afd566dc32b2ac22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Forecasting
67 rdf:type schema:DefinedTerm
68 Ncbce0da4c45f4b1480f95b7c8dfa015d schema:name doi
69 schema:value 10.1038/sj.clpt.6100063
70 rdf:type schema:PropertyValue
71 Ncef136755a1b4756bc4d4325ba002d88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Humans
73 rdf:type schema:DefinedTerm
74 Nf012d4789d0a4a419f9a7f4bd6403136 schema:name dimensions_id
75 schema:value pub.1001636899
76 rdf:type schema:PropertyValue
77 Nf7fb622de8de4be99f8d14a0603820f1 schema:name pubmed_id
78 schema:value 17259943
79 rdf:type schema:PropertyValue
80 anzsrc-for:22 schema:inDefinedTermSet anzsrc-for:
81 schema:name Philosophy and Religious Studies
82 rdf:type schema:DefinedTerm
83 anzsrc-for:2202 schema:inDefinedTermSet anzsrc-for:
84 schema:name History and Philosophy of Specific Fields
85 rdf:type schema:DefinedTerm
86 sg:journal.1017409 schema:issn 0009-9236
87 1532-6535
88 schema:name Clinical Pharmacology & Therapeutics
89 rdf:type schema:Periodical
90 sg:person.01107576476.16 schema:affiliation https://www.grid.ac/institutes/grid.417587.8
91 schema:familyName Woodcock
92 schema:givenName J
93 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107576476.16
94 rdf:type schema:Person
95 https://www.grid.ac/institutes/grid.417587.8 schema:alternateName United States Food and Drug Administration
96 schema:name Deputy Commissioner for Operations, Food and Drug Administration Rockville Maryland USA
97 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...